Abstract 1136: Tumor uptake and biodistribution of89Zirconium-labeled ipilimumab in patients with metastatic melanoma during ipilimumab treatment
Sign Up to like & getrecommendations! Published in 2019 at "Tumor Biology"
DOI: 10.1158/1538-7445.am2019-1136
Abstract: Introduction Ipilimumab, a monoclonal antibody targeting CTLA-4, is approved for the treatment of metastatic melanoma and significantly improves overall survival. Because of the high costs and the potential serious toxicity of ipilimumab, it is of… read more here.
Keywords: labeled ipilimumab; treatment; ipilimumab; metastatic melanoma ... See more keywords